Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02199873Phase 1Completed
Phase 1, randomised, double-blind trial in asthma comparing BIIX 1 XX with Placebo (2 arms). Primary endpoints: Number of subjects with adverse events at 3 months, Number of subjects with abnormal changes in laboratory parameters at 8 days and 2 more. Started Jun 1998; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02199873.